Sofinnova Investments
QUIT icon

Sofinnova Investments’s Achieve Life Sciences QUIT Stock Holding History

Sofinnova Investments’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,306,482
Closed -$4.6M – 66
2024
Q4 		$4.6M Sell
1,306,482
-207,550
-14% -$940K 0.34% 40
2024
Q3 		$7.18M Buy
1,514,032
+125,660
+9% +$574K 0.57% 39
2024
Q2 		$6.53M Sell
1,388,372
-129,858
-9% -$626K 0.34% 52
2024
Q1 		$6.9M Buy
+1,518,230
New +$6.74M 0.38% 45

Other funds holding QUIT

Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
J. Goldman & Co
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Sofinnova Investments's QUIT Position: Q1 2025 in Review

Sofinnova Investments sold out of Achieve Life Sciences (QUIT) in Q1 2025, closing a stake of 1,306,482 shares — an estimated $4.6M sold.

Sofinnova Investments first reported a position in QUIT in Q1 2024 and held it in 4 quarters. The position peaked at $7.18M in Q3 2024. 73 funds tracked by Wall St. Rank hold QUIT as of Q1 2025.

  • Sofinnova Investments reported no remaining Achieve Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Sofinnova Investments sold 1,306,482 Achieve Life Sciences shares in Q1 2025, an estimated $4.6M.
  • Sofinnova Investments first reported a position in Achieve Life Sciences in Q1 2024 and held it in 4 quarters.
  • Sofinnova Investments's Achieve Life Sciences position peaked at $7.18M in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2025.

Based on Sofinnova Investments's 13F filing for Q1 2025, filed 15 May 2025.